Matches in Wikidata for { <http://www.wikidata.org/entity/Q90947103> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q90947103 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90947103 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90947103 description "scientific article published on 24 October 2019" @default.
- Q90947103 description "wetenschappelijk artikel" @default.
- Q90947103 description "наукова стаття, опублікована 24 жовтня 2019" @default.
- Q90947103 name "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 name "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 type Item @default.
- Q90947103 label "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 label "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 prefLabel "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 prefLabel "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 P1433 Q90947103-C92D14CC-FBA5-4246-9315-07813D1621C7 @default.
- Q90947103 P1476 Q90947103-C80B1A60-E6A7-4A6E-94AA-2B183FDAF2CA @default.
- Q90947103 P2093 Q90947103-1F45C6DC-27EC-4AA4-BA3A-7E1F666FDC19 @default.
- Q90947103 P2093 Q90947103-261BF69F-8175-4405-A2E6-DE893BEFC8E6 @default.
- Q90947103 P2093 Q90947103-8390B415-17ED-4077-A817-F26EB8CF4006 @default.
- Q90947103 P2093 Q90947103-BB70A676-92F6-48D1-9ABB-1286DAA436C7 @default.
- Q90947103 P2093 Q90947103-C4D06779-4C7E-4DC0-AA23-818A0079D9A1 @default.
- Q90947103 P275 Q90947103-ca14a44c-b512-43ab-9559-2b6e9d70bc47 @default.
- Q90947103 P31 Q90947103-1073721E-6E42-421C-BBEF-5A34300200DA @default.
- Q90947103 P356 Q90947103-AE6C21DE-D3A7-405C-A099-996AE3323959 @default.
- Q90947103 P433 Q90947103-8F5307B7-A5A0-441E-9A91-034A42A25F84 @default.
- Q90947103 P478 Q90947103-51883D41-D970-4592-BB45-EC3A24B11DDB @default.
- Q90947103 P577 Q90947103-FA7A2DAC-7F85-4624-BEC9-3D4183D8163D @default.
- Q90947103 P6216 Q90947103-6fcee95b-4602-4c5b-a0f9-2ac13b19ee9b @default.
- Q90947103 P698 Q90947103-6A0E81F6-E238-4C16-8CE2-330A95CC9C6F @default.
- Q90947103 P932 Q90947103-A15AD1D6-956A-438B-87C7-4734BAD66B7F @default.
- Q90947103 P356 CANCERS11111642 @default.
- Q90947103 P698 31653096 @default.
- Q90947103 P1433 Q27722963 @default.
- Q90947103 P1476 "Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma" @default.
- Q90947103 P2093 "C Lance Cowey" @default.
- Q90947103 P2093 "Mark Faries" @default.
- Q90947103 P2093 "Michelle Offner" @default.
- Q90947103 P2093 "Omid Hamid" @default.
- Q90947103 P2093 "Richard D Carvajal" @default.
- Q90947103 P275 Q20007257 @default.
- Q90947103 P31 Q13442814 @default.
- Q90947103 P356 "10.3390/CANCERS11111642" @default.
- Q90947103 P433 "11" @default.
- Q90947103 P478 "11" @default.
- Q90947103 P577 "2019-10-24T00:00:00Z" @default.
- Q90947103 P6216 Q50423863 @default.
- Q90947103 P698 "31653096" @default.
- Q90947103 P932 "6895913" @default.